{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,13]],"date-time":"2026-02-13T15:05:01Z","timestamp":1770995101040,"version":"3.50.1"},"reference-count":54,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,1,21]],"date-time":"2026-01-21T00:00:00Z","timestamp":1768953600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,2,13]],"date-time":"2026-02-13T00:00:00Z","timestamp":1770940800000},"content-version":"vor","delay-in-days":23,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"the Korea government (MSIT)"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cancer Cell Int"],"DOI":"10.1186\/s12935-026-04186-6","type":"journal-article","created":{"date-parts":[[2026,1,21]],"date-time":"2026-01-21T13:47:27Z","timestamp":1769003247000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Neuregulin induces prostate cancer cell migration via HER3\/HER2-FAK\/Src signaling axis"],"prefix":"10.1186","volume":"26","author":[{"given":"Eun Jin","family":"Lim","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yu Jeong","family":"Yoon","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yehwon","family":"Kim","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hyung Hwan","family":"Moon","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yung-Hyun","family":"Choi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Young-Ho","family":"Kim","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2026,1,21]]},"reference":[{"issue":"1","key":"4186_CR1","first-page":"10","volume":"75","author":"RL Siegel","year":"2025","unstructured":"Siegel RL, Kratzer TB, Giaquinto AN, Sung H, Jemal A. Cancer statistics, 2025. CA Cancer J Clin. 2025;75(1):10\u201345.","journal-title":"CA Cancer J Clin"},{"issue":"3","key":"4186_CR2","first-page":"229","volume":"74","author":"F Bray","year":"2024","unstructured":"Bray F, Laversanne M, Sung H, Ferlay J, Siegel RL, Soerjomataram I, Jemal A. Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2024;74(3):229\u201363.","journal-title":"CA Cancer J Clin"},{"issue":"5","key":"4186_CR3","doi-asserted-by":"publisher","first-page":"646","DOI":"10.1016\/j.cell.2011.02.013","volume":"144","author":"D Hanahan","year":"2011","unstructured":"Hanahan D, Weinberg RA. Hallmarks of cancer: the next generation. Cell. 2011;144(5):646\u201374.","journal-title":"Cell"},{"issue":"14","key":"4186_CR4","doi-asserted-by":"publisher","first-page":"5649","DOI":"10.1158\/0008-5472.CAN-10-1040","volume":"70","author":"JE Talmadge","year":"2010","unstructured":"Talmadge JE, Fidler IJ. AACR centennial series: the biology of cancer metastasis: historical perspective. Cancer Res. 2010;70(14):5649\u201369.","journal-title":"Cancer Res"},{"issue":"6","key":"4186_CR5","doi-asserted-by":"publisher","first-page":"437","DOI":"10.1038\/nrn2392","volume":"9","author":"L Mei","year":"2008","unstructured":"Mei L, Xiong WC. Neuregulin 1 in neural development, synaptic plasticity and schizophrenia. Nat Rev Neurosci. 2008;9(6):437\u201352.","journal-title":"Nat Rev Neurosci"},{"issue":"1","key":"4186_CR6","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1016\/S0014-4827(02)00099-X","volume":"284","author":"T Holbro","year":"2003","unstructured":"Holbro T, Civenni G, Hynes NE. The erbb receptors and their role in cancer progression. Exp Cell Res. 2003;284(1):99\u2013110.","journal-title":"Exp Cell Res"},{"issue":"3","key":"4186_CR7","doi-asserted-by":"publisher","first-page":"243","DOI":"10.2174\/1389450053765879","volume":"6","author":"N Normanno","year":"2005","unstructured":"Normanno N, Bianco C, Strizzi L, Mancino M, Maiello MR, De Luca A, et al. The ErbB receptors and their ligands in cancer: an overview. Curr Drug Targets. 2005;6(3):243\u201357.","journal-title":"Curr Drug Targets"},{"issue":"7","key":"4186_CR8","doi-asserted-by":"publisher","first-page":"505","DOI":"10.1038\/nrm1962","volume":"7","author":"A Citri","year":"2006","unstructured":"Citri A, Yarden Y. EGF-ERBB signalling: towards the systems level. Nat Rev Mol Cell Biol. 2006;7(7):505\u201316.","journal-title":"Nat Rev Mol Cell Biol"},{"issue":"2","key":"4186_CR9","doi-asserted-by":"publisher","first-page":"215","DOI":"10.1007\/s10911-008-9083-7","volume":"13","author":"DF Stern","year":"2008","unstructured":"Stern DF. ERBB3\/HER3 and ERBB2\/HER2 duet in mammary development and breast cancer. J Mammary Gland Biol Neoplasia. 2008;13(2):215\u201323.","journal-title":"J Mammary Gland Biol Neoplasia"},{"key":"4186_CR10","doi-asserted-by":"publisher","DOI":"10.1186\/1476-4598-13-105","volume":"13","author":"J Ma","year":"2014","unstructured":"Ma J, Lyu H, Huang J, Liu B. Targeting of erbB3 receptor to overcome resistance in cancer treatment. Mol Cancer. 2014;13:105.","journal-title":"Mol Cancer"},{"issue":"7126","key":"4186_CR11","doi-asserted-by":"publisher","first-page":"437","DOI":"10.1038\/nature05474","volume":"445","author":"NV Sergina","year":"2007","unstructured":"Sergina NV, Rausch M, Wang D, Blair J, Hann B, Shokat KM, Moasser MM. Escape from HER-family tyrosine kinase inhibitor therapy by the kinase-inactive HER3. Nature. 2007;445(7126):437\u201341.","journal-title":"Nature"},{"issue":"4","key":"4186_CR12","doi-asserted-by":"publisher","first-page":"453","DOI":"10.1038\/sj.bjc.6603910","volume":"97","author":"AC Hsieh","year":"2007","unstructured":"Hsieh AC, Moasser MM. Targeting HER proteins in cancer therapy and the role of the non-target HER3. Br J Cancer. 2007;97(4):453\u20137.","journal-title":"Br J Cancer"},{"issue":"7","key":"4186_CR13","doi-asserted-by":"publisher","first-page":"463","DOI":"10.1038\/nrc2656","volume":"9","author":"J Baselga","year":"2009","unstructured":"Baselga J, Swain SM. Novel anticancer targets: revisiting ERBB2 and discovering ERBB3. Nat Rev Cancer. 2009;9(7):463\u201375.","journal-title":"Nat Rev Cancer"},{"issue":"5","key":"4186_CR14","doi-asserted-by":"publisher","first-page":"341","DOI":"10.1038\/nrc1609","volume":"5","author":"NE Hynes","year":"2005","unstructured":"Hynes NE, Lane HA. ERBB receptors and cancer: the complexity of targeted inhibitors. Nat Rev Cancer. 2005;5(5):341\u201354.","journal-title":"Nat Rev Cancer"},{"issue":"2","key":"4186_CR15","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1016\/j.ceb.2008.12.010","volume":"21","author":"NE Hynes","year":"2009","unstructured":"Hynes NE, MacDonald G. ErbB receptors and signaling pathways in cancer. Curr Opin Cell Biol. 2009;21(2):177\u201384.","journal-title":"Curr Opin Cell Biol"},{"issue":"9","key":"4186_CR16","doi-asserted-by":"publisher","first-page":"663","DOI":"10.1038\/nrc3559","volume":"13","author":"N Tebbutt","year":"2013","unstructured":"Tebbutt N, Pedersen MW, Johns TG. Targeting the ERBB family in cancer: couples therapy. Nat Rev Cancer. 2013;13(9):663\u201373.","journal-title":"Nat Rev Cancer"},{"issue":"8","key":"4186_CR17","doi-asserted-by":"publisher","first-page":"565","DOI":"10.1038\/ncb823","volume":"4","author":"N Carter","year":"2002","unstructured":"Carter N, Nakamoto T, Hirai H, Hunter T. EphrinA1-induced cytoskeletal re-organization requires FAK and p130Cas. Nat Cell Biol. 2002;4(8):565\u201373.","journal-title":"Nat Cell Biol"},{"issue":"1","key":"4186_CR18","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1038\/nrm1549","volume":"6","author":"SK Mitra","year":"2005","unstructured":"Mitra SK, Hanson DA, Schlaepfer DD. Focal adhesion kinase: in command and control of cell motility. Nat Rev Mol Cell Biol. 2005;6(1):56\u201368.","journal-title":"Nat Rev Mol Cell Biol"},{"issue":"11","key":"4186_CR19","doi-asserted-by":"publisher","first-page":"802","DOI":"10.1038\/nrm2996","volume":"11","author":"MC Frame","year":"2010","unstructured":"Frame MC, Patel H, Serrels B, Lietha D, Eck MJ. The FERM domain: organizing the structure and function of FAK. Nat Rev Mol Cell Biol. 2010;11(11):802\u201314.","journal-title":"Nat Rev Mol Cell Biol"},{"issue":"1","key":"4186_CR20","doi-asserted-by":"publisher","first-page":"248","DOI":"10.1007\/s11033-025-10296-7","volume":"52","author":"J Aakriti","year":"2025","unstructured":"Aakriti J, Vithalkar MP, Maity S, Baby K, Nagareddy PR, Nayak Y. Focal adhesion kinase (FAK): emerging target for drug-resistant malignant tumors. Mol Biol Rep. 2025;52(1):248.","journal-title":"Mol Biol Rep"},{"issue":"48","key":"4186_CR21","doi-asserted-by":"publisher","first-page":"7906","DOI":"10.1038\/sj.onc.1208160","volume":"23","author":"SJ Parsons","year":"2004","unstructured":"Parsons SJ, Parsons JT. Src family kinases, key regulators of signal transduction. Oncogene. 2004;23(48):7906\u20139.","journal-title":"Oncogene"},{"key":"4186_CR22","doi-asserted-by":"publisher","first-page":"513","DOI":"10.1146\/annurev.cellbio.13.1.513","volume":"13","author":"SM Thomas","year":"1997","unstructured":"Thomas SM, Brugge JS. Cellular functions regulated by Src family kinases. Annu Rev Cell Dev Biol. 1997;13:513\u2013609.","journal-title":"Annu Rev Cell Dev Biol"},{"issue":"1","key":"4186_CR23","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1016\/j.cell.2016.06.028","volume":"166","author":"MA Nieto","year":"2016","unstructured":"Nieto MA, Huang RY, Jackson RA, Thiery JP. EMT. Cell. 2016;166(1):21\u201345.","journal-title":"Cell"},{"issue":"6","key":"4186_CR24","doi-asserted-by":"publisher","first-page":"415","DOI":"10.1038\/nrc2131","volume":"7","author":"H Peinado","year":"2007","unstructured":"Peinado H, Olmeda D, Cano A. Snail, Zeb and bHLH factors in tumour progression: an alliance against the epithelial phenotype? Nat Rev Cancer. 2007;7(6):415\u201328.","journal-title":"Nat Rev Cancer"},{"issue":"2","key":"4186_CR25","doi-asserted-by":"publisher","first-page":"84","DOI":"10.1038\/35000034","volume":"2","author":"E Batlle","year":"2000","unstructured":"Batlle E, Sancho E, Franc\u00ed C, Dom\u00ednguez D, Monfar M, Baulida J, et al. The transcription factor snail is a repressor of E-cadherin gene expression in epithelial tumour cells. Nat Cell Biol. 2000;2(2):84\u20139.","journal-title":"Nat Cell Biol"},{"issue":"3","key":"4186_CR26","doi-asserted-by":"publisher","first-page":"178","DOI":"10.1038\/nrm3758","volume":"15","author":"S Lamouille","year":"2014","unstructured":"Lamouille S, Xu J, Derynck R. Molecular mechanisms of epithelial\u2013mesenchymal transition. Nat Rev Mol Cell Biol. 2014;15(3):178\u201396.","journal-title":"Nat Rev Mol Cell Biol"},{"issue":"9","key":"4186_CR27","doi-asserted-by":"publisher","first-page":"4364","DOI":"10.3390\/ijms26094364","volume":"26","author":"S Ghafoor","year":"2025","unstructured":"Ghafoor S, Garcia E, Jay DJ, Persad S. Molecular mechanisms regulating epithelial mesenchymal transition (EMT) to promote cancer progression. Int J Mol Sci. 2025;26(9):4364.","journal-title":"Int J Mol Sci"},{"issue":"9","key":"4186_CR28","doi-asserted-by":"publisher","first-page":"2294","DOI":"10.1016\/j.febslet.2006.03.041","volume":"580","author":"F Alimirah","year":"2006","unstructured":"Alimirah F, Chen J, Basrawala Z, Xin H, Choubey D. DU-145 and PC-3 human prostate cancer cell lines express androgen receptor: implications for the androgen receptor functions and regulation. FEBS Lett. 2006;580(9):2294\u2013300.","journal-title":"FEBS Lett"},{"issue":"10","key":"4186_CR29","doi-asserted-by":"publisher","first-page":"3270","DOI":"10.7150\/jca.112954","volume":"16","author":"S Li","year":"2025","unstructured":"Li S, Zhao W, Wang D, Chen L, Feng Y, Sun P. Neuregulin-1 correlates to early castration-resistant prostate cancer after prostate cancer patients receiving androgen deprivation therapy. J Cancer. 2025;16(10):3270\u201382.","journal-title":"J Cancer"},{"key":"4186_CR30","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2121-10-78","volume":"10","author":"Y Zhang","year":"2009","unstructured":"Zhang Y, Opresko L, Shankaran H, Chrisler WB, Wiley HS, Resat H. HER\/ErbB receptor interactions and signaling patterns in human mammary epithelial cells. BMC Cell Biol. 2009;10:78.","journal-title":"BMC Cell Biol"},{"key":"4186_CR31","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1016\/1040-8428(94)00144-I","volume":"19","author":"DS Salomon","year":"1995","unstructured":"Salomon DS, Brandt R, Ciardiello F, Normanno N. Epidermal growth factor-related peptides and their receptors in human malignancies. Crit Rev Oncol Hematol. 1995;19:183\u2013232.","journal-title":"Crit Rev Oncol Hematol"},{"key":"4186_CR32","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1038\/35052073","volume":"2","author":"Y Yarden","year":"2001","unstructured":"Yarden Y, Sliwkowski MX. Untangling the erbb signaling network. Nat Rev Mol Cell Biol. 2001;2:127\u201337.","journal-title":"Nat Rev Mol Cell Biol"},{"issue":"1","key":"4186_CR33","doi-asserted-by":"publisher","DOI":"10.1038\/s41392-021-00571-x","volume":"6","author":"L Bu","year":"2021","unstructured":"Bu L, Wang H, Pan JA, Chen L, Xing F, Wu J, et al. PTEN suppresses tumorigenesis by directly dephosphorylating Akt. Signal Transduct Target Ther. 2021;6(1):262.","journal-title":"Signal Transduct Target Ther"},{"issue":"8","key":"4186_CR34","doi-asserted-by":"publisher","DOI":"10.3390\/cancers11081076","volume":"11","author":"F Luongo","year":"2019","unstructured":"Luongo F, Colonna F, Calap\u00e0 F, Vitale S, Fiori ME, De Maria R. PTEN tumor-suppressor: the dam of stemness in cancer. Cancers (Basel). 2019;11(8):1076.","journal-title":"Cancers (Basel)"},{"issue":"8","key":"4186_CR35","doi-asserted-by":"publisher","first-page":"553","DOI":"10.1038\/nrc3309","volume":"12","author":"Y Yarden","year":"2012","unstructured":"Yarden Y, Pines G. The ERBB network: at last, cancer therapy meets systems biology. Nat Rev Cancer. 2012;12(8):553\u201363.","journal-title":"Nat Rev Cancer"},{"issue":"Pt 22","key":"4186_CR36","doi-asserted-by":"publisher","first-page":"4251","DOI":"10.1242\/jcs.00118","volume":"115","author":"P Nagy","year":"2002","unstructured":"Nagy P, Vereb G, Sebesty\u00e9n Z, Horv\u00e1th G, Lockett SJ, Damjanovich S, Park JW, Jovin TM, Sz\u00f6llosi J. Lipid rafts and the local density of erbb proteins influence the biological role of homo- and heteroassociations of erbb2. J Cell Sci. 2002;115(Pt 22):4251\u201362.","journal-title":"J Cell Sci"},{"issue":"13","key":"4186_CR37","doi-asserted-by":"publisher","first-page":"3645","DOI":"10.1158\/0008-5472.CAN-18-0430","volume":"78","author":"A Ruiz-Saenz","year":"2018","unstructured":"Ruiz-Saenz A, Dreyer C, Campbell MR, Steri V, Gulizia N, Moasser MM. HER2 amplification in tumors activates PI3K\/Akt signaling independent of HER3. Cancer Res. 2018;78(13):3645\u201358.","journal-title":"Cancer Res"},{"issue":"1","key":"4186_CR38","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1038\/ncb2386","volume":"14","author":"E Sandilands","year":"2011","unstructured":"Sandilands E, Serrels B, McEwan DG, Morton JP, Macagno JP, McLeod K, Stevens C, Brunton VG, Langdon WY, Vidal M, Sansom OJ, Dikic I, Wilkinson S, Frame MC. Autophagic targeting of Src promotes cancer cell survival following reduced FAK signalling. Nat Cell Biol. 2011;14(1):51\u201360.","journal-title":"Nat Cell Biol"},{"issue":"18","key":"4186_CR39","doi-asserted-by":"publisher","first-page":"3510","DOI":"10.1111\/febs.15011","volume":"286","author":"A Parkin","year":"2019","unstructured":"Parkin A, Man J, Timpson P, Pajic M. Targeting the complexity of Src signalling in the tumour microenvironment of pancreatic cancer: from mechanism to therapy. FEBS J. 2019;286(18):3510\u201339.","journal-title":"FEBS J"},{"issue":"4","key":"4186_CR40","doi-asserted-by":"publisher","first-page":"1089","DOI":"10.1007\/s13402-025-01069-2","volume":"48","author":"EJ Lim","year":"2025","unstructured":"Lim EJ, Yoon YJ, Heo J, Kim S, Choi YH, Kim YH. Neuregulin-induced HER3 activation drives migration in head and neck squamous cell carcinoma via HER2 and FAK signaling pathways. Cell Oncol (Dordr). 2025;48(4):1089\u2013103.","journal-title":"Cell Oncol (Dordr)"},{"issue":"1","key":"4186_CR41","doi-asserted-by":"publisher","DOI":"10.1186\/s40364-025-00745-7","volume":"13","author":"Z Liu","year":"2025","unstructured":"Liu Z, Zhang X, Ben T, Li M, Jin Y, Wang T, et al. Focal adhesion in the tumour metastasis: from molecular mechanisms to therapeutic targets. Biomark Res. 2025;13(1):38.","journal-title":"Biomark Res"},{"issue":"1","key":"4186_CR42","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-020-17415-x","volume":"11","author":"A Abu-Thuraia","year":"2020","unstructured":"Abu-Thuraia A, Goyette MA, Boulais J, Delliaux C, Apcher C, Schott C, et al. AXL confers cell migration and invasion by hijacking a PEAK1-regulated focal adhesion protein network. Nat Commun. 2020;11(1):3586.","journal-title":"Nat Commun"},{"issue":"24","key":"4186_CR43","doi-asserted-by":"publisher","first-page":"3172","DOI":"10.1038\/onc.2013.279","volume":"33","author":"SH Kao","year":"2014","unstructured":"Kao SH, Wang WL, Chen CY, Chang YL, Wu YY, Wang YT, Wang SP, Nesvizhskii AI, Chen YJ, Hong TM, Yang PC. GSK3beta controls epithelial-mesenchymal transition and tumor metastasis by CHIP-mediated degradation of slug. Oncogene. 2014;33(24):3172\u201382.","journal-title":"Oncogene"},{"issue":"10","key":"4186_CR44","doi-asserted-by":"publisher","first-page":"931","DOI":"10.1038\/ncb1173","volume":"6","author":"BP Zhou","year":"2004","unstructured":"Zhou BP, Deng J, Xia W, Xu J, Li YM, Gunduz M, et al. Dual regulation of Snail by GSK-3beta-mediated phosphorylation in control of epithelial-mesenchymal transition. Nat Cell Biol. 2004;6(10):931\u201340.","journal-title":"Nat Cell Biol"},{"issue":"2","key":"4186_CR45","doi-asserted-by":"publisher","first-page":"194","DOI":"10.1016\/j.canlet.2008.05.045","volume":"273","author":"J Luo","year":"2009","unstructured":"Luo J. Glycogen synthase kinase 3beta (GSK3beta) in tumorigenesis and cancer chemotherapy. Cancer Lett. 2009;273(2):194\u2013200.","journal-title":"Cancer Lett"},{"issue":"7","key":"4186_CR46","doi-asserted-by":"publisher","DOI":"10.1042\/BSR20193514","volume":"41","author":"W Mai","year":"2021","unstructured":"Mai W, Kong L, Yu H, Bao J, Song C, Qu G. Glycogen synthase kinase 3beta promotes osteosarcoma invasion and migration via regulating PTEN and phosphorylation of focal adhesion kinase. Biosci Rep. 2021;41(7):BSR20193514.","journal-title":"Biosci Rep"},{"issue":"2","key":"4186_CR47","doi-asserted-by":"publisher","DOI":"10.1111\/cpr.13754","volume":"58","author":"Y Zhang","year":"2025","unstructured":"Zhang Y, Qin X, Guo R, Sun X, Zhao Z, Guo H, et al. Notch-1 regulates collective breast cancer cell migration by controlling intercellular junction and cytoskeletal organization. Cell Prolif. 2025;58(2):e13754.","journal-title":"Cell Prolif"},{"key":"4186_CR48","doi-asserted-by":"publisher","DOI":"10.1186\/s13046-014-0062-0","volume":"33","author":"S Kaufhold","year":"2014","unstructured":"Kaufhold S, Bonavida B. Central role of Snail1 in the regulation of emt and resistance in cancer: a target for therapeutic intervention. J Exp Clin Cancer Res. 2014;33:62.","journal-title":"J Exp Clin Cancer Res"},{"issue":"1","key":"4186_CR49","doi-asserted-by":"publisher","first-page":"1214","DOI":"10.1186\/s12885-023-11724-2","volume":"23","author":"F Li","year":"2023","unstructured":"Li F, Wang J, Yan YQ, Bai CZ, Guo JQ. CD147 promotes breast cancer migration and invasion by inducing epithelial-mesenchymal transition via the MAPK\/ERK signaling pathway. BMC Cancer. 2023;23(1):1214.","journal-title":"BMC Cancer"},{"key":"4186_CR50","doi-asserted-by":"crossref","unstructured":"Roskoski R Jr. Small molecule inhibitors targeting the EGFR\/ErbB family of protein-tyrosine kinases in human cancers. Pharmacol Res. 2019;139:395\u2013411.","DOI":"10.1016\/j.phrs.2018.11.014"},{"issue":"6","key":"4186_CR51","doi-asserted-by":"publisher","DOI":"10.3390\/cancers11060737","volume":"11","author":"DM Collins","year":"2019","unstructured":"Collins DM, Conlon NT, Kannan S, Verma CS, Eli LD, Lalani AS, et al. Preclinical characteristics of the irreversible pan-HER kinase inhibitor neratinib compared with lapatinib: implications for the treatment of HER2-positive and HER2-mutated breast cancer. Cancers (Basel). 2019;11(6):737.","journal-title":"Cancers (Basel)"},{"issue":"7","key":"4186_CR52","doi-asserted-by":"publisher","DOI":"10.3390\/ijms24076650","volume":"24","author":"YH Huang","year":"2023","unstructured":"Huang YH, Chen HK, Hsu YF, Chen HC, Chuang CH, Huang SW, et al. Src-FAK signaling mediates interleukin 6-induced HCT116 colorectal cancer epithelial-mesenchymal transition. Int J Mol Sci. 2023;24(7):6650.","journal-title":"Int J Mol Sci"},{"issue":"1","key":"4186_CR53","doi-asserted-by":"publisher","DOI":"10.1038\/s41420-025-02593-8","volume":"11","author":"F Nie","year":"2025","unstructured":"Nie F, Sun X, Sun J, Zhang J, Wang Y. Epithelial-mesenchymal transition in colorectal cancer metastasis and progression: molecular mechanisms and therapeutic strategies. Cell Death Discov. 2025;11(1):336.","journal-title":"Cell Death Discov"},{"issue":"7","key":"4186_CR54","doi-asserted-by":"publisher","first-page":"887","DOI":"10.1007\/s00702-010-0418-3","volume":"117","author":"M Shibuya","year":"2010","unstructured":"Shibuya M, Komi E, Wang R, Kato T, Watanabe Y, Sakai M, Ozaki M, Someya T, Nawa H. Measurement and comparison of serum neuregulin 1 immunoreactivity in control subjects and patients with schizophrenia: an influence of its genetic polymorphism. J Neural Transm (Vienna). 2010;117(7):887.","journal-title":"J Neural Transm (Vienna)"}],"container-title":["Cancer Cell International"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12935-026-04186-6","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12935-026-04186-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12935-026-04186-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,2,13]],"date-time":"2026-02-13T14:03:32Z","timestamp":1770991412000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12935-026-04186-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1,21]]},"references-count":54,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["4186"],"URL":"https:\/\/doi.org\/10.1186\/s12935-026-04186-6","relation":{},"ISSN":["1475-2867"],"issn-type":[{"value":"1475-2867","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,1,21]]},"assertion":[{"value":"23 September 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 January 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 January 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Institutional review board statement"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed consent"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"The Human Protein Atlas, available from\n                      \n                      .","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Supplementary Materials"}}],"article-number":"89"}}